Antimicrobial Activity of Plectasin NZ2114 in Combination with Cell Wall Targeting Antibiotics Against VanA-Type

Elena B M Breidenstein1, Patrice Courvalin1, Djalal Meziane-Cherif1

  • 1Department of Microbiology, Unité des Agents Antibactériens, Institut Pasteur , Paris, France .

Microbial Drug Resistance (Larchmont, N.Y.)
|March 19, 2015
PubMed

Insights

Antimicrobial peptide plectasin NZ2114 shows synergy with teicoplanin, moenomycin, and dalbavancin against vancomycin-resistant Enterococcus faecalis. These combinations may target different stages of bacterial cell wall synthesis, offering new therapeutic strategies.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Antimicrobial peptide plectasin exhibits activity against resistant bacteria.
  • Vancomycin-resistant Enterococcus faecalis (VRE) poses a significant clinical challenge.
  • Plectasin's efficacy against VRE is less understood compared to other resistant strains.

Purpose of the Study:

  • To evaluate the synergistic activity of plectasin NZ2114 in combination with cell wall-targeting antibiotics against vancomycin-resistant Enterococcus faecalis (VRE).
  • To investigate the mechanisms underlying observed synergistic interactions.
  • To explore potential novel therapeutic strategies for VRE infections.

Main Methods:

  • Disk agar-induction, double-disk assay, fractional inhibitory concentration (FIC) index determination, and time-kill curve analyses were employed.
  • Combinations of plectasin NZ2114 with various cell wall synthesis inhibitors were tested against VanA-type VRE.
  • Further synergistic interactions between other cell wall antibiotics were assessed.

Main Results:

  • Plectasin NZ2114 demonstrated synergistic effects when combined with teicoplanin, moenomycin, and dalbavancin against VRE.
  • Synergy was not observed with vancomycin, telavancin, penicillin G, bacitracin, ramoplanin, daptomycin, or fosfomycin.
  • Teicoplanin and moenomycin showed broad synergy with other antibiotics, suggesting involvement in peptidoglycan transglycosylation inhibition.

Conclusions:

  • Plectasin NZ2114 can potentiate the activity of specific cell wall-targeting antibiotics against VRE.
  • The observed synergies, particularly with teicoplanin and moenomycin, likely involve the inhibition of peptidoglycan transglycosylation.
  • These findings suggest that combinations targeting different stages of cell wall synthesis may offer effective therapeutic options against VRE.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
113
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
8.0K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
923
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K